enVVeno Medical Corporation
NVNO
$10.33
$0.333.30%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -18.71% | -7.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.58% | -15.96% | |||
| Operating Income | 6.58% | 15.96% | |||
| Income Before Tax | -3.02% | 17.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.02% | 17.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.02% | 17.69% | |||
| EBIT | 6.58% | 15.96% | |||
| EBITDA | 6.62% | 16.06% | |||
| EPS Basic | 2.77% | 23.21% | |||
| Normalized Basic EPS | 10.18% | 20.77% | |||
| EPS Diluted | 2.77% | 23.21% | |||
| Normalized Diluted EPS | 10.18% | 20.77% | |||
| Average Basic Shares Outstanding | 5.96% | 7.17% | |||
| Average Diluted Shares Outstanding | 5.96% | 7.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||